UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

The case for levetiracetam to be included in essential medicine lists

Singh, G; Sander, JW; (2023) The case for levetiracetam to be included in essential medicine lists. The Lancet Regional Health - Southeast Asia , 14 , Article 100211. 10.1016/j.lansea.2023.100211. Green open access

[thumbnail of 1-s2.0-S2772368223000719-main.pdf]
Preview
 Text
1-s2.0-S2772368223000719-main.pdf - Published Version
Download (160kB) | Preview
Type: Article
Title: The case for levetiracetam to be included in essential medicine lists
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.lansea.2023.100211
Publisher version: https://doi.org/10.1016/j.lansea.2023.100211
Language: English
Additional information: © 2023 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Clinical and Experimental Epilepsy
URI: https://discovery.ucl.ac.uk/id/eprint/10172296
Downloads since deposit
17Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item